Heart Failure

This special issue of the Handbook of Experimental Pharmacology on Heart Failure covers the entire spectrum of the field, from the current understanding and definitions of heart failure, to epidemiology and the importance of co-morbidities, clinical trial design and biomarkers, as well as imaging te...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Bauersachs, Johann (Επιμελητής έκδοσης), Butler, Javed (Επιμελητής έκδοσης), Sandner, Peter (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2017.
Σειρά:Handbook of Experimental Pharmacology, 243
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 02853nam a22005055i 4500
001 978-3-319-59659-4
003 DE-He213
005 20170609154117.0
007 cr nn 008mamaa
008 170609s2017 gw | s |||| 0|eng d
020 |a 9783319596594  |9 978-3-319-59659-4 
024 7 |a 10.1007/978-3-319-59659-4  |2 doi 
040 |d GrThAP 
050 4 |a RM1-950 
072 7 |a MMG  |2 bicssc 
072 7 |a MED071000  |2 bisacsh 
082 0 4 |a 615  |2 23 
245 1 0 |a Heart Failure  |h [electronic resource] /  |c edited by Johann Bauersachs, Javed Butler, Peter Sandner. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2017. 
300 |a IX, 581 p. 100 illus., 30 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Handbook of Experimental Pharmacology,  |x 0171-2004 ;  |v 243 
505 0 |a Introduction -- Epidemiology -- Clinical trial design, endpoints and regulatory requirements. Biomarkers HFpEF/HFrEF. Imaging Technologies / MRI and Echo. Comorbidities in HF. Current Guideline based therapy of HFreF and HFpEF. New and Emerging Therapies and Targets. Ivabradine -- Beta3 agonists -- Novel MRAs -- pGCs and Natriuretic peptides -- sGC stimulators -- PDE’s -- Adenosin and A1 Agonists -- Myosin heavy chain / Troponin -- Stem cells -- Diuretics and Vasopressin -- GeneTherapy -- RNA-based therapies and micro RNAs -- Cardiac myosin activation using gene therapy -- Bendavia – mitochondrial therapies -- WNT signaling -- Anticoagulation therapy and NOACS in HF -- Potassium Binders -- Iron. . 
520 |a This special issue of the Handbook of Experimental Pharmacology on Heart Failure covers the entire spectrum of the field, from the current understanding and definitions of heart failure, to epidemiology and the importance of co-morbidities, clinical trial design and biomarkers, as well as imaging technologies. The main focus of this book is to review current and emerging heart failure therapies and potential targets for treatment. 
650 0 |a Medicine. 
650 0 |a Human physiology. 
650 0 |a Pharmacology. 
650 0 |a Cardiology. 
650 1 4 |a Biomedicine. 
650 2 4 |a Pharmacology/Toxicology. 
650 2 4 |a Cardiology. 
650 2 4 |a Human Physiology. 
700 1 |a Bauersachs, Johann.  |e editor. 
700 1 |a Butler, Javed.  |e editor. 
700 1 |a Sandner, Peter.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319596587 
830 0 |a Handbook of Experimental Pharmacology,  |x 0171-2004 ;  |v 243 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-59659-4  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)